Khiron Life Sciences Corp.
Rank 51
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$1.7620
USD
4.04%
Market cap
$200,743,003
Total volume
$1,311,419
Shares outstanding
113,927,120
Rank 51
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$1,035,785
|
78.98% |
$1.7620
|
| KHRNF |
Total volume
$275,634
|
21.02% |
Stock price
$1.7662
|
Chart